Rapid phage susceptibility determination using a semi-automated bioluminescent ATP assay
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.00782-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Houssein Chalhoub und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Environmental and Occupational Health, Ecole de Santé Publique - Université Libre de Bruxelles, Brussels, Belgium. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Luminescent Measurements, Bacteriophages, Bacteria. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Région Wallonne WIN2WAL program.
Abstract (Originalsprache)
Antimicrobial resistance is a major threat to human health. Phage therapy is a promising alternative to antibiotics, yet routine diagnostic tools capable of rapidly determining phage susceptibility are lacking. Our goal was to develop a diagnostic tool providing easy-to-interpret in vitro phage activity results within a clinically relevant time frame. We developed a prototype based on bioluminescence emitted by adenosine triphosphate (ATP) release during phage-mediated bacterial lysis. Ten phages were tested against 20 clinical isolates of four species: Pseudomonas aeruginosa , Staphylococcus aureus , Escherichia coli , and Klebsiella pneumoniae . Overall concordance with double agar overlay (DAO) was fair (72%). The prototype showed high sensitivity (94.5%) at detecting weak killers and high specificity (87%) at identifying strong killer phages. Most discordances involved DAO weak killers classified as active by the prototype. Most of these discordant phage-bacteria couples produced a spot in the spot test, suggesting the assay may detect but not distinguish killing without replication from killing with replication. The method showed high repeatability and reproducibility. A few aberrant species specificity results highlighted the need for routine controls. Results from prospective urine samples were obtained within an average of 5 h. IMPORTANCE The lack of reproducible user-friendly phage susceptibility testing that can timely inform clinical decisions remains a major barrier to the routine clinical use of phages. We developed a high-throughput, semi-automated prototype that delivers easy-to-interpret phage susceptibility results for four bacterial species within 5 h in a “real-life” clinical flow. However, the correlation between in vitro lytic activity and clinical outcomes still needs to be established to meet regulatory requirements for in vitro diagnostic (IVD) medical devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Environmental and Occupational Health, Ecole de Santé Publique - Université Libre de Bruxelles, Brussels, Belgium.
- Research & Innovation Unit, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles, Brussels, Belgium.
- SYNLAB Belgium SRL, SYNLAB Laboratoire Collard, Liège, Belgium.
- Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles, Brussels, Belgium.
- Inteliphage, Mont-St-Guibert, Belgium.
- Faculté de Médecine, Institute for Interdisciplinary Innovation in Healthcare (I3h), Solvay Brussels School of Economics and Management, Université Libre de Bruxelles (ULB), Brussels, Belgium.
ORCID-Profile: Valéry Daubie, Hafid Dahma, Bob Blasdel, Johan Quintens, Olivier Vandenberg, Marie Hallin
Förderung
- Région Wallonne WIN2WAL program
Zitieren
APA
Chalhoub, H., Daubie, V., Dahma, H., Blasdel, B., Tytgat, I., Quintens, J., Vandenberg, O., & Hallin, M. (2026). Rapid phage susceptibility determination using a semi-automated bioluminescent ATP assay. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00782-26
Vancouver
Chalhoub H, Daubie V, Dahma H, Blasdel B, Tytgat I, Quintens J, et al. Rapid phage susceptibility determination using a semi-automated bioluminescent ATP assay. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00782-26
BibTeX
@article{Chalhoub2026,
author = {Chalhoub, Houssein and Daubie, Valéry and Dahma, Hafid and Blasdel, Bob and Tytgat, Isabelle and Quintens, Johan and Vandenberg, Olivier and Hallin, Marie},
title = {Rapid phage susceptibility determination using a semi-automated bioluminescent ATP assay},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.00782-26}
}
EUVIMED